Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)

Aims: Limited data are available on the long-term outcome following PCI with paclitaxel-eluting stent (PES) implantation in patients with unprotected left main coronary artery (LMCA). The objective of this study was to evaluate "real world" long-term outcome following paclitaxel-eluting stent (PES) implantation for unprotected LMCA disease in patients enrolled in the TRUE registry. Methods and results: From March 2003 to October 2004, 93 consecutive patients (81.7% male) underwent PCI for unprotected LMCA disease. Surveillance angiography was performed at 6.8±3.3 months follow-up. The target lesion involved the distal LMCA in 68 (73.1%) patients. Double stenting techniques were performed in 46 (67.6%) distal LMCA, of these 50% were stented using the Crush technique. Clinical follow-up was complete in all patients with 85.8% angiographic follow-up rate. In-segment restenosis occurred in 16 (20.3%) patients and was focal in 72.4% of cases and significantly higher in patients with distal LMCA (36.8% vs. 13.6%, p<0.04). At a median follow-up of 1,450 days (IQR 1281-1595), the overall incidence of MACE was 35.5% and the TLR rate was 25.8% and significantly higher in patients with bifurcation stenting (32.3% vs. 8%, p<0.02). The estimated cardiac survival rate at one and four years was 96.7% and 93.3%, respectively. Total mortality rate was 14.1% and cardiac was 6.5%. There was one (1.1%) definite stent thrombosis (ST) and one (1.1%) probable ST. Conclusions: Treatment of unprotected LMCA disease with PES, after four years follow-up, appears to be safe and effective with a low rate of cardiac mortality and overall risk of ST. The need for target lesion revascularisation in 25.8% of patients highlights the need for more effective PCI especially in patients with distal LMCA disease.

[1]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[2]  P. Serruys,et al.  Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. , 2008, European heart journal.

[3]  I. Palacios,et al.  Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease The DELFT ( Drug Eluting stent for LeFT main ) Registry , 2008 .

[4]  J. Schneider,et al.  Unprotected left main disease managed with drug‐eluting stents: Long‐term outcome of 100 patients with increased surgical risk , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  P. Teirstein,et al.  A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. , 2008, American heart journal.

[6]  Vladimir Dzavik,et al.  Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  G. Stone,et al.  Assessing intermediate left main coronary lesions using intravascular ultrasound. , 2007, American heart journal.

[8]  S. de Servi,et al.  A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). , 2007, European heart journal.

[9]  G. Biondi-Zoccai,et al.  Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents. , 2007, The American journal of cardiology.

[10]  P. Serruys,et al.  Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry , 2007, Circulation.

[11]  C. Di Mario,et al.  Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. , 2007, International journal of cardiology.

[12]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[13]  N. Shammas.  Trifurcating coronary artery disease: a proposed classification and treatment methodology. , 2007, The Journal of invasive cardiology.

[14]  O. Alfieri,et al.  Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience , 2006, Circulation.

[15]  P. Serruys,et al.  Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. , 2006, Journal of the American College of Cardiology.

[16]  P. Teirstein,et al.  Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. , 2006, Journal of the American College of Cardiology.

[17]  P. Shah,et al.  Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.

[18]  P. Serruys,et al.  Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. , 2006, Journal of the American College of Cardiology.

[19]  Alfonso Medina,et al.  Una clasificación simple de las lesiones coronarias en bifurcación , 2006 .

[20]  J. Suárez de Lezo,et al.  [A new classification of coronary bifurcation lesions]. , 2006, Revista espanola de cardiologia.

[21]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  K. Seung,et al.  Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. , 2005, Journal of the American College of Cardiology.

[23]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[24]  P. Serruys,et al.  Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH) , 2005, Circulation.

[25]  I. Iakovou,et al.  Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.

[26]  Seung‐Jung Park,et al.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.

[27]  M. Pan,et al.  Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. , 2004, American heart journal.

[28]  P. Serruys,et al.  Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. , 2004, The American journal of cardiology.

[29]  Antonio Colombo,et al.  Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.

[30]  C. Leclercq,et al.  Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery , 2002, Heart.

[31]  E. Antman,et al.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat , 2002, Circulation.

[32]  Seung‐Jung Park,et al.  Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. , 2001, Journal of the American College of Cardiology.

[33]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.

[34]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[35]  B. Chaitman,et al.  Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. , 1995, Circulation.

[36]  A. Bernstein,et al.  A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.